NCT05407441 2026-04-13
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
Dana-Farber Cancer Institute
Phase 1/2 Active not recruiting
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
University of Florida
Sarcoma Oncology Research Center, LLC
Massachusetts General Hospital